About Erbi Bio
Erbi Bio is a company based in Stoneham (United States) founded in 2016 was acquired by Merck in December 2022. Erbi Bio has raised $7.8 million across 2 funding rounds from investors including Merck, Jaguar Health and Michael Chambers. Erbi Bio operates in a competitive market with competitors including Proklean Technologies, Limula, PBS Biotech, RheaVita and m2p-labs, among others.
- Headquarter Stoneham, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Erbi Bio
Unlock access to complete
Software Development Team
17 people
Sales and Marketing
16 people
Senior Team
6 people
Leadership Team
6 people
Project Team
6 people
Human Resources and Administration
5 people
Product Management Team
4 people
Legal and Compliance
3 people
Unlock access to complete
Funding Insights of Erbi Bio
Erbi Bio has successfully raised a total of $7.8M across 2 strategic funding rounds. The most recent funding activity was a Angel Round of $4 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Erbi Bio
Erbi Bio has secured backing from 4 investors, including angel and institutional investors. Prominent investors backing the company include Merck, Jaguar Health and Michael Chambers.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Novel gastrointestinal products for humans and animals are developed sustainably.
|
Locked | Locked | Locked | |
|
Merck is engaged in science and technology solutions globally.
|
Locked | Locked | Locked | |
|
MC
Michael Chambers |
Angel investor focusing on Indian startups, tech enthusiast
|
Locked | Locked | Locked |
Investor details for Erbi Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Erbi Bio
Investment portfolio details for Erbi Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Erbi Bio
Detailed financials for Erbi Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Erbi Bio Comparisons
Peer comparison for Erbi Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Erbi Bio
Erbi Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Proklean Technologies, Limula, PBS Biotech, RheaVita and m2p-labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Probiotic-based cleaning agents are manufactured for industrial use.
|
|
| Locked | Locked | Locked |
Modular solutions for on-demand cell therapy manufacturing are provided.
|
|
| Locked | Locked | Locked |
Developer of single-use bioreactors for the production of vaccines, therapeutic proteins, and cell therapies
|
|
| Locked | Locked | Locked |
Instruments for continuous freeze-drying are developed by RheaVita.
|
|
| Locked | Locked | Locked |
Micro-bioreactors are provided for screening and bioprocess development.
|
|
| Locked | Locked | Locked |
Bioreactors and systems for cultivated meat production are developed.
|
Detailed competitors of Erbi Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Erbi Bio
Complete news archive for Erbi Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Erbi Bio
Erbi Bio was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Erbi Bio is headquartered in Stoneham, United States. It is registered at Stoneham, Massachusetts, United States.
Michael Chiu is the current CEO of Erbi Bio.
Erbi Bio is a funded company, having raised a total of $7.8M across 2 funding rounds to date.
Erbi Bio was established in 2016 in Stoneham, United States, within the biotechnology sector. Microbioreactors are produced for research applications, supporting scientific experimentation in controlled environments. Operations are centered on manufacturing these devices, with distribution handled through the companys domain, erbi-bio.com. Leadership is provided by CEO Michael Chiu, overseeing activities in the research tools industry.
Erbi Bio's top competitors include Proklean Technologies, PBS Biotech and RheaVita.
Erbi Bio has 4 investors. Key investors include Merck, Jaguar Health, Michael Chambers, and Martin Madaus.